EFFECT OF AN ORAL DOSE OF FERROUS SULFATE ON URINARY ESCRETION OF EPCIDINA IN PATIENTS AFFECTED BY EMOCROMATOSI.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-000170-40-IT

Enrollment

Unknown

Registered

2005-07-06

Start date

2005-02-07

Completion date

Unknown

Last updated

2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TREATMENT OF EMOCROMATOSIS MedDRA version: 6.1 Level: SOC Classification code 10005329

Interventions

Product Name: FERRO SULFATE Product Code: NA Pharmaceutical Form: Tablet INN or Proposed INN: FERROUS SULFATE NATURE MADE CAS Number: 7782-63-0 Current Sponsor code: NA Concentration unit: mg milligra

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026